Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SERA | US
0.06
3.11%
Healthcare
Diagnostics & Research
30/06/2024
12/03/2026
1.99
1.95
2.08
1.86
Sera Prognostics Inc. a women's health diagnostic company discovers develops and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions including preeclampsia molecular time-to-birth gestational diabetes mellitus fetal growth restriction stillbirth and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City Utah.
View LessStrength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
53.2%1 month
47.5%3 months
67.5%6 months
71.6%-
-
4.28
0.02
0.02
-0.61
1.93K
-
-34.53M
66.40M
66.40M
-
-38.55K
-
-80.50
-44.77
8.09
3.45
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.74
Range1M
0.98
Range3M
2.06
Rel. volume
1.73
Price X volume
227.06K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ENDRA Life Sciences Inc | NDRA | Diagnostics & Research | 3.27 | 60.13M | -3.25% | n/a | 3.13% |
| Precipio Inc | PRPO | Diagnostics & Research | 28.775 | 42.65M | 2.88% | n/a | 9.66% |
| Cytosorbents Corporation | CTSO | Diagnostics & Research | 0.7257 | 39.50M | 0.10% | n/a | 159.92% |
| BioTelemetry Inc | BEAT | Diagnostics & Research | 1.47 | 39.05M | 8.09% | n/a | 0.00% |
| Neuronetics Inc | STIM | Diagnostics & Research | 1.27 | 38.48M | -1.55% | n/a | 323.03% |
| Biomerica Inc | BMRA | Diagnostics & Research | 1.97 | 33.14M | -2.48% | n/a | 13.22% |
| STAR EQUITY HOLDINGS INC | STRR | Diagnostics & Research | 9.915 | 31.94M | 1.17% | n/a | 26.85% |
| MYnd Analytics Inc | MYND | Diagnostics & Research | 0.49 | 22.37M | 15.89% | n/a | 117.50% |
| VolitionRx Limited | VNRX | Diagnostics & Research | 0.1961 | 18.06M | -3.26% | n/a | -26.88% |
| bioAffinity Technologies Inc. | BIAF | Diagnostics & Research | 1.07 | 14.43M | -5.31% | n/a | 40.20% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ILAG | ILAG | Building Products & Equipment | 2.25 | 40.64M | -14.12% | n/a | 5.48% |
| Reading International Inc | RDI | Media - Diversified | 1.1 | 31.05M | -2.65% | n/a | 4054.78% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 2.05 | 29.96M | -8.07% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.5643 | 10.90M | -3.54% | n/a | 58.43% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.3953 | 3.76M | 18.11% | n/a | 19.98% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.36 | 3.47M | -2.02% | n/a | 17.32% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.4 | 1.32M | -0.41% | n/a | 0.00% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0092 | 848.37K | 29.58% | n/a | -37.05% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.61 | 12.67 | Cheaper |
| Ent. to Revenue | 1,928.54 | 44.00 | Expensive |
| PE Ratio | - | 40.09 | - |
| Price to Book | 4.28 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 67.54 | 59.59 | Par |
| Debt to Equity | 0.02 | -14.36 | Expensive |
| Debt to Assets | 0.02 | 0.34 | Cheaper |
| Market Cap | 66.40M | 13.71B | Emerging |